Susanne Fuessel - Search Results

Year	Number of Results
2003	2
2004	9
2005	5
2006	7
2007	3
2008	4
2009	3
2010	3
2011	2
2012	4
2013	6
2014	7
2015	7
2016	4
2017	4
2018	3
2019	4
2020	6
2021	2
2022	4
2023	1
2024	2

1

Blood-Based DNA Methylation Analysis by Multiplexed OBBPA-ddPCR to Verify Indications for Prostate Biopsies in Suspected Prostate Cancer Patients.

Friedemann M, Jandeck C, Tautz L, Gutewort K, von Rein L, Sukocheva O, Fuessel S, Menschikowski M. Friedemann M, et al. Among authors: fuessel s. Cancers (Basel). 2024 Mar 28;16(7):1324. doi: 10.3390/cancers16071324. Cancers (Basel). 2024. PMID: 38611002 Free PMC article.

2

Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors.

Schüttke V, Kusiek C, Fuessel S, Thomas C, Buerk BT, Erdmann K. Schüttke V, et al. Among authors: fuessel s. Clin Transl Oncol. 2024 May;26(5):1117-1128. doi: 10.1007/s12094-023-03317-z. Epub 2023 Sep 11. Clin Transl Oncol. 2024. PMID: 37695463 Free PMC article.

3

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.

Linke D, Donix L, Peitzsch C, Erb HHH, Dubrovska A, Pfeifer M, Thomas C, Fuessel S, Erdmann K. Linke D, et al. Among authors: fuessel s. Int J Mol Sci. 2022 Dec 30;24(1):666. doi: 10.3390/ijms24010666. Int J Mol Sci. 2022. PMID: 36614114 Free PMC article.

4

Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.

Dutta S, Polavaram NS, Islam R, Bhattacharya S, Bodas S, Mayr T, Roy S, Albala SAY, Toma MI, Darehshouri A, Borkowetz A, Conrad S, Fuessel S, Wirth M, Baretton GB, Hofbauer LC, Ghosh P, Pienta KJ, Klinkebiel DL, Batra SK, Muders MH, Datta K. Dutta S, et al. Among authors: fuessel s. Oncogene. 2022 Jul;41(30):3747-3760. doi: 10.1038/s41388-022-02382-y. Epub 2022 Jun 27. Oncogene. 2022. PMID: 35754042 Free PMC article.

5

Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA.

Dreymann N, Wuensche J, Sabrowski W, Moeller A, Czepluch D, Vu Van D, Fuessel S, Menger MM. Dreymann N, et al. Among authors: fuessel s. Int J Mol Sci. 2022 Apr 28;23(9):4890. doi: 10.3390/ijms23094890. Int J Mol Sci. 2022. PMID: 35563278 Free PMC article.

6

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines.

Donix L, Erb HHH, Peitzsch C, Dubrovska A, Pfeifer M, Thomas C, Fuessel S, Erdmann K. Donix L, et al. Among authors: fuessel s. J Cancer Res Clin Oncol. 2022 Jun;148(6):1313-1324. doi: 10.1007/s00432-022-03914-5. Epub 2022 Jan 12. J Cancer Res Clin Oncol. 2022. PMID: 35020044 Free PMC article.

7

Increased Sensitivity of Detection of RASSF1A and GSTP1 DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCR.

Friedemann M, Horn F, Gutewort K, Tautz L, Jandeck C, Bechmann N, Sukocheva O, Wirth MP, Fuessel S, Menschikowski M. Friedemann M, et al. Among authors: fuessel s. Cancers (Basel). 2021 Sep 4;13(17):4459. doi: 10.3390/cancers13174459. Cancers (Basel). 2021. PMID: 34503269 Free PMC article.

8

Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions.

Keck B, Borkowetz A, Poellmann J, Jansen T, Fischer M, Fuessel S, Kahlmeyer A, Wirth M, Huber J, Cavallaro A, Hammon M, Platzek I, Hartmann A, Baretton G, Kunath F, Sikic D, Taubert H, Wullich B, Erdmann K, Wach S. Keck B, et al. Among authors: fuessel s. Cells. 2021 May 25;10(6):1315. doi: 10.3390/cells10061315. Cells. 2021. PMID: 34070529 Free PMC article.

9

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.

Erb HHH, Bodenbender J, Handle F, Diehl T, Donix L, Tsaur I, Gleave M, Haferkamp A, Huber J, Fuessel S, Juengel E, Culig Z, Thomas C. Erb HHH, et al. Among authors: fuessel s. PLoS One. 2020 Aug 13;15(8):e0237248. doi: 10.1371/journal.pone.0237248. eCollection 2020. PLoS One. 2020. PMID: 32790723 Free PMC article.

10

Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer.

Borkowetz A, Lohse-Fischer A, Scholze J, Lotzkat U, Thomas C, Wirth MP, Fuessel S, Erdmann K. Borkowetz A, et al. Among authors: fuessel s. Diagnostics (Basel). 2020 Aug 9;10(8):578. doi: 10.3390/diagnostics10080578. Diagnostics (Basel). 2020. PMID: 32784833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year